Skip to main content
. 2012 Aug 23;3:338. doi: 10.3389/fphys.2012.00338

Figure 1.

Figure 1

Effect of pravastatin treatment on circulating nucleotide ATP (A) and ADP (B) levels and soluble nucleotidase ADPase (C) and 5′-nucleotidase activities (D) in type 1 diabetic patients (pravastatin n = 22, placebo n = 20). Control refers to healthy subjects (n = 41). *p < 0.05; **p < 0.01.